MORPHAGEN, INC. STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
AGREEMENT AND PLAN OF MERGERMerger Agreement • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
by and amongRegistration Rights Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 1998 • Invitrogen Corp • New York
LICENSE AGREEMENT (SK# 2302)License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
EXHIBIT 10.13 INDEMNIFICATION AGREEMENT This Indemnification Agreement made and entered into this 14 day of Sept., 2000 ("Agreement"), by and between Invitrogen Corporation, a Delaware corporation (together with any successor or successors and...Indemnification Agreement • March 21st, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
Exhibit 10.3 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between LIFE TECHNOLOGIES, INC., a Delaware Corporation (the "Company"), and J. Stark Thompson, Ph.D. (the "Executive"), dated as of the 13th day of February 1997. The Board of Directors of the...Change-in-Control Agreement • November 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
INDENTURE DATED AS OF DECEMBER 11, 2001Indenture • March 11th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
PURCHASE AGREEMENTPurchase Agreement • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances)
UNDERWRITING AGREEMENTUnderwriting Agreement • October 22nd, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
EXHIBIT 2.1 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 11th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
ARTICLE 1 TERM OF AGREEMENTEmployment Agreement • September 14th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
5781 Van Allen Way Carlsbad, CaliforniaLease • March 11th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances)
500,000,000 2 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2006 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 11th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
AGREEMENT AND PLAN OF MERGERMerger Agreement • July 10th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
3,500,000 SharesUnderwriting Agreement • January 28th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
ANDRights Agreement • March 30th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
by and amongPatent License Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances)
SERVICE AGREEMENTService Agreement • March 21st, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances)
Exhibit 10.2 CONTRACT OF SALE THIS CONTRACT OF SALE ("THIS CONTRACT") is made and entered into as of March 7, 2001 (the "CONTRACT DATE") by and between INVITROGEN CORPORATION, a Delaware corporation ("SELLER"), and HUMAN GENOME SCIENCES, INC., a...Contract of Sale • May 15th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • Maryland
Exhibit 10.47 RECORDING REQUESTED BY: AND WHEN RECORDED MAIL TO: Gray Cary Ware & Freidenrich LLP Att'n: Joseph A. Delaney, Esq. 401 B Street, Suite 2000 San Diego, CA 92101-4240 ----------------------------------------------------------...Deed of Trust • August 13th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances)
EXHIBIT 10.54 UNIVERSITY RESEARCH PARK GROUND LEASE This Lease is made, executed and delivered as of the 1st day of October, 1998, by and between University Research Park, Inc., a Wisconsin nonprofit corporation with its principal place of business...Ground Lease • May 12th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • Wisconsin
INDENTUREIndenture • March 14th, 2000 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
PURCHASE AGREEMENT THIS AGREEMENT is made and is effective this 1st day of, JULY 1994, (the "Effective Date") by and between CAYLA having its technical offices located at Centre Commercial de Gros, Avenue de Larrieu, 31094 Toulouse Cedex, France and...Purchase Agreement • December 10th, 1998 • Invitrogen Corp
CREDIT AGREEMENT dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, as U.S. Borrower, APPLIED BIOSYSTEMS FINANCE B.V., LIFE TECHNOLOGIES EUROPE B.V., and LIFE TECHNOLOGIES FINANCE LIMITED, as Foreign Borrowers, THE LENDERS FROM TIME TO...Credit Agreement • February 14th, 2012 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Credit Agreement (“Agreement”) dated as of February 14, 2012 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “U.S. Borrower”), APPLIED BIOSYSTEMS FINANCE B.V., a company organized under the laws of the Netherlands (“ABFBV”), LIFE TECHNOLOGIES EUROPE B.V., a company organized under the laws of the Netherlands (“LTEBV”), LIFE TECHNOLOGIES FINANCE LIMITED, a company organized under the laws of Scotland (“LTFLTD”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”) and BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer.
Exhibit 10.1 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between INVITROGEN CORPORATION, a Delaware Corporation (the "Company"), and Lyle C. Turner (the "Executive"), dated as of the 1st day of June 2001. The Board of Directors of the Company (the...Change-in-Control Agreement • August 9th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
CREDIT AGREEMENT dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, THE LENDERS FROM TIME TO TIME PARTY HERETO, BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY...Credit Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances) • New York
Credit Agreement (“Agreement”) dated as of November 21, 2008 among LIFE TECHNOLOGIES CORPORATION, a Delaware corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and, individually, a “Lender”), BANK OF AMERICA, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer, UBS SECURITIES LLC and MORGAN STANLEY SENIOR FUNDING, INC. as Co-Syndication Agents, and DnB NOR BANK ASA and THE BANK OF NOVA SCOTIA, as Co-Documentation Agents.
CHANGE-IN-CONTROL AGREEMENTChange in Control Agreement • March 2nd, 2007 • Invitrogen Corp • Biological products, (no disgnostic substances) • Delaware
This CHANGE IN CONTROL AGREEMENT (“the Agreement”) by and between INVITROGEN CORPORATION, a Delaware Corporation (the “Company”), and [Name] (the “Executive”), dated as of the th Day of , 20 .
EXHIBIT 99.1 INVITROGEN CORPORATION NONSTATUTORY STOCK OPTION AGREEMENT THIS NONSTATUTORY STOCK OPTION AGREEMENT (the "OPTION AGREEMENT") is made and entered into as of the Date of Option Grant, by and between Invitrogen Corporation (the "COMPANY")...Nonstatutory Stock Option Agreement • May 30th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
PURCHASE AGREEMENT THIS AGREEMENT is made and is effective this 1st day of, JULY 1994, (the "Effective Date") by and between CAYLA having its technical offices located at Centre Commercial de Gros, Avenue de Larrieu, 31094 Toulouse Cedex, France and...Purchase Agreement • February 25th, 1999 • Invitrogen Corp • Biological products, (no disgnostic substances)
Exhibit 10.2 CHANGE-IN-CONTROL AGREEMENT AGREEMENT by and between INVITROGEN CORPORATION, a Delaware Corporation (the "Company"), and James R. Glynn (the "Executive"), dated as of the 1st day of June 2001. The Board of Directors of the Company (the...Change-in-Control Agreement • August 9th, 2001 • Invitrogen Corp • Biological products, (no disgnostic substances) • New York
INVITROGEN CORPORATION RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • May 10th, 2004 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
Invitrogen Corporation (the “Company”) has granted to Karen Gibson (the “Participant”) an Award consisting of Shares subject to the terms and conditions set forth in this Restricted Stock Agreement (the “Agreement”). The Award has been granted pursuant to the Invitrogen Corporation 2002 Stock Incentive Plan (formerly the Molecular Probes, Inc. 2002 Stock Incentive Plan) (the “Plan”) and as an essential and material inducement to the Participant accepting employment with the Company. By signing this Agreement, the Participant: (a) represents that the Participant has read and is familiar with the terms and conditions of the Award, this Agreement and the Plan, (b) accepts the Award subject to all of the terms and conditions of this Agreement and the Plan, (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement, and (d) acknowledges receipt of a copy of this Agreement and the Plan.
EXHIBIT 99.2 INVITROGEN CORPORATION RESTRICTED STOCK AGREEMENT Invitrogen Corporation (the "COMPANY") has granted to Gregory T. Lucier (the "PARTICIPANT") an Award consisting of Shares subject to the terms and conditions set forth in this Restricted...Restricted Stock Agreement • May 30th, 2003 • Invitrogen Corp • Biological products, (no disgnostic substances) • California
EXHIBIT (d)(4) CONFIDENTIALITY AGREEMENT This confidentiality agreement ("Agreement") is entered into by and between Invitrogen Corporation ("Invitrogen") and InforMax, Inc. ("Participant"). In consideration of the mutual agreements contained herein...Confidentiality Agreement • October 29th, 2002 • Invitrogen Corp • Biological products, (no disgnostic substances)
AMENDMENT TO CHANGE IN CONTROL AGREEMENTChange-in-Control Agreement • November 28th, 2008 • Life Technologies Corp • Biological products, (no disgnostic substances)
THIS AMENDMENT to the CHANGE-IN-CONTROL AGREEMENT (the “Amendment”) is made and entered into as of November 21, 2008, by and between INVITROGEN CORPORATION, a Delaware corporation (the “Company”) and David F. Hoffmeister (“Executive”).
